{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:46:18Z","timestamp":1795106778807,"version":"4.10.3"},"reference-count":185,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Cognitive impairment is the core precursor to dementia and other cognitive disorders. Current hypotheses suggest that they share a common pathological basis, such as inflammation, restricted neurogenesis, neuroendocrine disorders, and the destruction of neurovascular units. Fibroblast growth factors (FGFs) are cell growth factors that play essential roles in various pathophysiological processes via paracrine or autocrine pathways. This system consists of FGFs and their receptors (FGFRs), which may hold tremendous potential to become a new biological marker in the diagnosis of dementia and other cognitive disorders, and serve as a potential target for drug development against dementia and cognitive function impairment. Here, we review the available evidence detailing the relevant pathways mediated by multiple FGFs and FGFRs, and recent studies examining their role in the pathogenesis and treatment of cognitive disorders and dementia.<\/jats:p>","DOI":"10.3389\/fnins.2023.1136266","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T04:48:32Z","timestamp":1683262112000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["The fibroblast growth factor system in cognitive disorders and dementia"],"prefix":"10.3389","volume":"17","author":[{"given":"Wujianwen","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manman","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","article-title":"Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.3390\/cells10102591","article-title":"Lipid profiling of Alzheimer's disease brain highlights enrichment in glycerol(phospho)lipid, and sphingolipid metabolism","volume":"10","author":"Akyol","year":"2021","journal-title":"Cells"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1016\/j.bbadis.2018.06.003","article-title":"Interaction of glucocorticoids with FXR\/FGF19\/FGF21-mediated ileum-liver crosstalk. Biochimica et biophysica acta","volume":"1864","author":"Al-Aqil","year":"2018","journal-title":"Mol Basis Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s12640-018-9914-2","article-title":"Protective effects of fibroblast growth factor 21 against amyloid-Beta-induced toxicity in SH-SY5Y cells","volume":"34","author":"Amiri","year":"2018","journal-title":"Neurotox. Res."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1017\/S1092852918001347","article-title":"State of the science on mild cognitive impairment (MCI)","volume":"24","author":"Anderson","year":"2019","journal-title":"CNS Spectr."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12974-022-02457-3","article-title":"SUN11602, a bFGF mimetic, modulated neuroinflammation, apoptosis and calcium-binding proteins in an in vivo model of MPTP-induced nigrostriatal degeneration","volume":"19","author":"Ardizzone","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"11953","DOI":"10.1073\/pnas.1510456112","article-title":"Fibroblast growth factor 9 is a novel modulator of negative affect","volume":"112","author":"Aurbach","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/ptr.6810","article-title":"Carnosic acid ameliorates depressive-like symptoms along with the modulation of FGF9 in the hippocampus of middle carotid artery occlusion-induced Sprague Dawley rats","volume":"35","author":"Azhar","year":"2021","journal-title":"Phytother. Res."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.annonc.2020.06.018","article-title":"Phase I, first-in-human study of futibatinib, a highly selective, irreversible FGFR1-4 inhibitor in patients with advanced solid tumors","volume":"31","author":"Bahleda","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1093\/brain\/awaa224","article-title":"Functional cognitive disorder: dementia's blind spot. Brain: a","volume":"143","author":"Ball","year":"2020","journal-title":"J. Neurol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"100138","DOI":"10.1016\/j.xcrm.2020.100138","article-title":"Metabolic network analysis reveals altered bile acid synthesis and metabolism in Alzheimer's disease","volume":"1","author":"Baloni","year":"2020","journal-title":"Cell Rep Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrd2792","article-title":"The FGF family: biology, pathophysiology and therapy","volume":"8","author":"Beenken","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"a015958","DOI":"10.1101\/cshperspect.a015958","article-title":"Molecular mechanisms of fibroblast growth factor signaling in physiology and pathology","volume":"5","author":"Belov","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2014.05.009","article-title":"Depression and dementia: cause, consequence or coincidence?","volume":"79","author":"Bennett","year":"2014","journal-title":"Maturitas"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000065683","article-title":"Fiblast (trafermin) in acute stroke: results of the European-Australian phase II\/III safety and efficacy trial","volume":"14","author":"Bogousslavsky","year":"2002","journal-title":"Cerebrovasc. Dis."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrneurol.2011.60","article-title":"Depression and risk of developing dementia","volume":"7","author":"Byers","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fnagi.2019.00269","article-title":"Is AD a stress-related disorder? Focus on the HPA Axis and its promising therapeutic targets","volume":"11","author":"Canet","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.arr.2017.03.003","article-title":"The relevance of \u03b1-KLOTHO to the central nervous system: some key questions","volume":"36","author":"Cararo-Lopes","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/STROKEAHA.121.035488","article-title":"Cerebral small vessel disease and depression among intracerebral hemorrhage survivors","volume":"53","author":"Castello","year":"2022","journal-title":"Stroke"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/ijnp\/pyx093","article-title":"FGF21 is associated with metabolic effects and treatment response in depressed bipolar II disorder patients treated with valproate","volume":"21","author":"Chang","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3988\/jcn.2020.16.1.29","article-title":"Plasma fibroblast growth factor 23 concentration is associated with intracranial cerebral atherosclerosis in acute ischemic stroke patients","volume":"16","author":"Chang","year":"2020","journal-title":"J. Clin. Neurol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1231970","DOI":"10.1155\/2022\/1231970","article-title":"\u2206nFGF1 protects-cells against high glucose-induced apoptosis via the AMPK\/SIRT1\/PGC-1 Axis","volume":"2022","author":"Chen","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"101133","DOI":"10.1016\/j.redox.2019.101133","article-title":"Fibroblast growth factor 21 ameliorates neurodegeneration in rat and cellular models of Alzheimer's disease","volume":"22","author":"Chen","year":"2019","journal-title":"Redox Biol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1089\/neu.2017.5271","article-title":"FGF21 protects the blood-brain barrier by upregulating PPARgamma via FGFR1\/beta-klotho after traumatic brain injury","volume":"35","author":"Chen","year":"2018","journal-title":"J. Neurotrauma"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3389\/fnmol.2019.00328","article-title":"Low and high molecular weight FGF-2 have differential effects on astrocyte proliferation, but are both protective against A\u03b2-induced cytotoxicity","volume":"12","author":"Chen","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"19796","DOI":"10.1073\/pnas.0709805104","article-title":"Insulin stimulates the cleavage and release of the extracellular domain of klotho by ADAM10 and ADAM17","volume":"104","author":"Chen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"tkac005","DOI":"10.1093\/burnst\/tkac005","article-title":"Roles of the fibroblast growth factor signal transduction system in tissue injury repair","volume":"10","author":"Chen","year":"2022","journal-title":"Burns Trauma"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1039\/d1fo02965g","article-title":"Carnosic acid ameliorated A\u03b2-mediated (amyloid-\u03b2 peptide) toxicity, cholinergic dysfunction and mitochondrial defect in of Alzheimer's model","volume":"13","author":"Chen","year":"2022","journal-title":"Food Funct."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pneurobio.2013.06.004","article-title":"Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies","volume":"108","author":"Chen","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"114046","DOI":"10.1016\/j.jep.2021.114046","article-title":"Paeoniflorin exerts antidepressant-like effects through enhancing neuronal FGF-2 by microglial inactivation","volume":"274","author":"Cheng","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000494139","article-title":"Tauroursodeoxycholic acid ameliorates lipopolysaccharide-induced depression like behavior in mice via the inhibition of Neuroinflammation and Oxido-Nitrosative stress","volume":"103","author":"Cheng","year":"2019","journal-title":"Pharmacology"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-008-8440-4","article-title":"High molecular weight FGF2: the biology of a nuclear growth factor","volume":"66","author":"Chlebova","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.freeradbiomed.2015.08.011","article-title":"FGF9-induced changes in cellular redox status and HO-1 upregulation are FGFR-dependent and proceed through both ERK and AKT to induce CREB and Nrf2 activation","volume":"89","author":"Chuang","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s11357-020-00287-w","article-title":"Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer's disease in comparison with healthy aging","volume":"43","author":"Conte","year":"2021","journal-title":"GeroScience"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1176\/ajp.2006.163.12.2164","article-title":"Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia","volume":"163","author":"Csernansky","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/exnr.1993.1202","article-title":"Neuritic involvement within bFGF immunopositive plaques of Alzheimer's disease","volume":"124","author":"Cummings","year":"1993","journal-title":"Exp. Neurol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2215\/CJN.06040710","article-title":"Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options","volume":"6","author":"Cunningham","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fphar.2019.00060","article-title":"Fibroblast growth factors in depression","volume":"10","author":"Deng","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1161\/CIRCRESAHA.116.308426","article-title":"Vascular Cognitive Impairment","volume":"120","author":"Dichgans","year":"2017","journal-title":"Circ. Res."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e00093","DOI":"10.1042\/AN20120021","article-title":"Fueling and imaging brain activation","volume":"4","author":"Dienel","year":"2012","journal-title":"ASN Neuro"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s13105-019-00675-7","article-title":"FGF19 subfamily members: FGF19 and FGF21","volume":"75","author":"Dolegowska","year":"2019","journal-title":"J. Physiol. Biochem."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/hdi.12100","article-title":"FGF-23 and cognitive performance in hemodialysis patients. Hemodialysis international","volume":"18","author":"Drew","year":"2014","journal-title":"Int Symp Home Hemodial"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/ki.2013.437","article-title":"Cognitive impairment in chronic kidney disease: keep vascular disease in mind","volume":"85","author":"Drew","year":"2014","journal-title":"Kidney Int."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1212\/WNL.0b013e3181eccfa2","article-title":"Mild cognitive impairment in prediagnosed Huntington disease","volume":"75","author":"Duff","year":"2010","journal-title":"Neurology"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/JCP.0000000000000163","article-title":"Impact of lithium treatment on FGF-23 serum concentrations in depressive patients","volume":"34","author":"Fakhri","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ijpharm.2011.12.008","article-title":"Enhancement of nose-to-brain delivery of basic fibroblast growth factor for improving rat memory impairments induced by co-injection of \u03b2-amyloid and ibotenic acid into the bilateral hippocampus","volume":"423","author":"Feng","year":"2012","journal-title":"Int. J. Pharm."},{"key":"ref48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0304-3940(97)00948-8","article-title":"Distribution of fibroblast growth factor receptor-1 (FGFR-1) and FGFR-3 in the hippocampus of patients with Alzheimer's disease","volume":"240","author":"Ferrer","year":"1998","journal-title":"Neurosci. Lett."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cytogfr.2016.08.004","article-title":"Growth factors as clinical biomarkers of prognosis and diagnosis in psychiatric disorders","volume":"32","author":"Galvez-Contreras","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/alz.12410","article-title":"White matter hyperintensity topography in Alzheimer's disease and links to cognition","volume":"18","author":"Garnier-Crussard","year":"2022","journal-title":"Alzheimers Dement."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nrendo.2017.78","article-title":"FGF1-a new weapon to control type 2 diabetes mellitus","volume":"13","author":"Gasser","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ajpath.2022.09.005","article-title":"Anti-Cholestatic therapy with Obeticholic acid improves short-term memory in bile duct ligated mice","volume":"193","author":"Gee","year":"2022","journal-title":"Am. J. Pathol."},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.03.024","article-title":"Blocking the FGF\/FGFR system as a two-compartment antiangiogenic\/antitumor approach in cancer therapy","author":"Giacomini","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.tem.2014.03.001","article-title":"FGF21-based pharmacotherapy--potential utility for metabolic disorders","volume":"25","author":"Gimeno","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/mp.2012.167","article-title":"Pathological parainflammation and endoplasmic reticulum stress in depression: potential translational targets through the CNS insulin, klotho and PPAR-gamma systems","volume":"18","author":"Gold","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"e158453","DOI":"10.1172\/JCI158453","article-title":"Biological aging processes underlying cognitive decline and neurodegenerative disease","volume":"132","author":"Gonzales","year":"2022","journal-title":"J. Clin. Invest."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.pnpbp.2012.12.010","article-title":"Gene expression analysis of novel genes in the prefrontal cortex of major depressive disorder subjects","volume":"43","author":"Goswami","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2019.01.016","article-title":"Brain insulin resistance: a treatment target for cognitive impairment and anhedonia in depression","volume":"315","author":"Hamer","year":"2019","journal-title":"Exp. Neurol."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"279","DOI":"10.15283\/ijsc18042","article-title":"FGF-17 from hypoxic human Wharton's jelly-derived mesenchymal stem cells is responsible for maintenance of cell proliferation at late passages","volume":"12","author":"Han","year":"2019","journal-title":"Int J Stem Cells"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/brain\/awaa405","article-title":"Depression, dementia and immune dysregulation","volume":"144","author":"Hayley","year":"2021","journal-title":"Brain"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1097\/WNR.0000000000001717","article-title":"Identification of the expression of farnesoid X receptor in astrocytes","volume":"32","author":"He","year":"2021","journal-title":"Neuroreport"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/08977199509036882","article-title":"Identification of fibroblast growth factor 9 (FGF9) as a high affinity, heparin dependent ligand for FGF receptors 3 and 2 but not for FGF receptors 1 and 4","volume":"12","author":"Hecht","year":"1995","journal-title":"Growth Factors"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/jnc.13585","article-title":"Fibroblast growth factor 23 signaling in hippocampal cells: impact on neuronal morphology and synaptic density","volume":"137","author":"Hensel","year":"2016","journal-title":"J. Neurochem."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nrendo.2014.129","article-title":"Therapy: FGF1 restores blood glucose levels and insulin sensitivity in diabetic mice","volume":"10","author":"Holmes","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3233\/JAD-150566","article-title":"Puerarin ameliorates D-galactose induced enhanced hippocampal neurogenesis and tau hyperphosphorylation in rat brain","volume":"51","author":"Hong","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"ref66","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/bbrc.1998.8239","article-title":"Structure and expression of a novel fibroblast growth factor, FGF-17, preferentially expressed in the embryonic brain","volume":"244","author":"Hoshikawa","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neubiorev.2019.03.018","article-title":"Glucose signaling in the brain and periphery to memory","volume":"110","author":"Hossain","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/2045-8118-10-32","article-title":"Fibroblast growth factor 19 entry into brain","volume":"10","author":"Hsuchou","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1002\/1873-3468.12373","article-title":"Identification of functional farnesoid X receptors in brain neurons","volume":"590","author":"Huang","year":"2016","journal-title":"FEBS Lett."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.3390\/ijms19071875","article-title":"FGF family: from drug development to clinical application","volume":"19","author":"Hui","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1016\/j.jacc.2019.04.034","article-title":"Vascular cognitive impairment and dementia: JACC scientific expert panel","volume":"73","author":"Iadecola","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s00702-019-02073-1","article-title":"FGF2 and dual agonist of NCAM and FGF receptor 1, Enreptin, rescue neurite outgrowth loss in hippocampal neurons expressing mutated huntingtin proteins","volume":"126","author":"Ilieva","year":"2019","journal-title":"J. Neural Transm."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41586-022-04722-0","article-title":"Young CSF restores oligodendrogenesis and memory in aged mice via Fgf17","volume":"605","author":"Iram","year":"2022","journal-title":"Nature"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.yjmcc.2006.09.002","article-title":"High-but not low-molecular weight FGF-2 causes cardiac hypertrophy in vivo; possible involvement of cardiotrophin-1","volume":"42","author":"Jiang","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3390\/ijms21030824","article-title":"FGF21 protects against aggravated blood-brain barrier disruption after ischemic focal stroke in diabetic db\/db male mice via cerebrovascular PPARgamma activation","volume":"21","author":"Jiang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"18189","DOI":"10.1073\/pnas.0506375102","article-title":"FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease","volume":"102","author":"Jin","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11357-022-00665-6","article-title":"Topographical differences in white matter hyperintensity burden and cognition in aging, MCI, and AD","volume":"45","author":"Kamal","year":"2022","journal-title":"GeroScience."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/ijms21041505","article-title":"Lipids and Alzheimer's disease","volume":"21","author":"Kao","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.neurobiolaging.2014.10.004","article-title":"Systemic administration of fibroblast growth factor-2 (FGF2) reduces BACE1 expression and amyloid pathology in APP23 mice","volume":"36","author":"Katsouri","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","article-title":"Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches","volume":"19","author":"Kellar","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J. Clin. Invest."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"E1339","DOI":"10.1073\/pnas.1102349108","article-title":"FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders","volume":"108","author":"Kiyota","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1172\/JCI94337","article-title":"Peripherally derived FGF21 promotes remyelination in the central nervous system","volume":"127","author":"Kuroda","year":"2017","journal-title":"J. Clin. Invest."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/bs.vh.2020.12.013","article-title":"Aging and FGF23-klotho system","volume":"115","author":"Kuro-O","year":"2021","journal-title":"Vitam. Horm."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cca.2013.04.013","article-title":"High cortisol levels are associated with cognitive impairment no-dementia (CIND) and dementia","volume":"423","author":"Lara","year":"2013","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"e0469","DOI":"10.1523\/ENEURO.0469-18.2019","article-title":"FGF-23 deficiency impairs hippocampal-dependent cognitive function","volume":"6","author":"Laszczyk","year":"2019","journal-title":"ENeuro"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"41230","DOI":"10.1074\/jbc.M111.270470","article-title":"Acidic fibroblast growth factor (FGF) potentiates glial-mediated neurotoxicity by activating FGFR2 IIIb protein","volume":"286","author":"Lee","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nature reviews","volume":"17","author":"Leng","year":"2021","journal-title":"Neurology"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s11684-019-0711-y","article-title":"The FGF metabolic axis","volume":"13","author":"Li","year":"2019","journal-title":"Front. Med."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neuroscience.2017.02.006","article-title":"Klotho regulates CA1 hippocampal synaptic plasticity","volume":"347","author":"Li","year":"2017","journal-title":"Neuroscience"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1201624","DOI":"10.1155\/2020\/1201624","article-title":"Cholic acid protects in vitro neurovascular units against oxygen and glucose deprivation-induced injury through the BDNF-TrkB signaling pathway","volume":"2020","author":"Li","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"670115","DOI":"10.3389\/fnagi.2021.670115","article-title":"Better identification of cognitive decline with Interleukin-2 than with amyloid and tau protein biomarkers in amnestic mild cognitive impairment","volume":"13","author":"Liang","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref94","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1007\/s12035-017-0544-0","article-title":"bFGF protects against oxygen glucose deprivation\/Reoxygenation-induced endothelial monolayer permeability via S1PR1-dependent mechanisms","volume":"55","author":"Lin","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.brainres.2011.07.028","article-title":"Impairment of spatial learning and memory in transgenic mice overexpressing human fibroblast growth factor-23","volume":"1412","author":"Liu","year":"2011","journal-title":"Brain Res."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.molmet.2017.12.003","article-title":"A gut-brain axis regulating glucose metabolism mediated by bile acids and competitive fibroblast growth factor actions at the hypothalamus","volume":"8","author":"Liu","year":"2018","journal-title":"Molec Metab"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.psychres.2017.01.075","article-title":"Negative correlation between cerebrospinal fluid FGF21 levels and BDI scores in male Chinese subjects","volume":"252","author":"Liu","year":"2017","journal-title":"Psychiatry Res."},{"key":"ref98","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12031-017-1023-9","article-title":"Basic fibroblast growth factor protects astrocytes against ischemia\/reperfusion injury by upregulating the Caveolin-1\/VEGF signaling pathway","volume":"64","author":"Liu","year":"2018","journal-title":"J. Mol. Neurosci."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.nbd.2012.09.003","article-title":"Tauroursodeoxycholic acid (TUDCA) supplementation prevents cognitive impairment and amyloid deposition in APP\/PS1 mice","volume":"50","author":"Lo","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"ref100","doi-asserted-by":"publisher","first-page":"7355","DOI":"10.1523\/JNEUROSCI.0115-20.2020","article-title":"Neuron-derived estrogen is critical for astrocyte activation and neuroprotection of the ischemic brain","volume":"40","author":"Lu","year":"2020","journal-title":"J. Neurosci."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/fcp.12367","article-title":"Tauroursodeoxycholic acid produces antidepressant-like effects in a chronic unpredictable stress model of depression via attenuation of neuroinflammation, oxido-nitrosative stress, and endoplasmic reticulum stress","volume":"32","author":"Lu","year":"2018","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref102","doi-asserted-by":"publisher","first-page":"8067045","DOI":"10.1155\/2019\/8067045","article-title":"Oxidative stress-related endothelial damage in vascular depression and vascular cognitive impairment: beneficial effects of aerobic physical exercise","volume":"2019","author":"Luca","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref103","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1080\/02713683.2020.1805768","article-title":"Expression of \u03b1-klotho is downregulated and associated with oxidative stress in the Lens in Streptozotocin-induced diabetic rats","volume":"46","author":"Ma","year":"2021","journal-title":"Curr. Eye Res."},{"key":"ref104","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.theriogenology.2015.03.031","article-title":"Fibroblast growth factor 17 and bone morphogenetic protein 15 enhance cumulus expansion and improve quality of in vitro-produced embryos in cattle","volume":"84","author":"Machado","year":"2015","journal-title":"Theriogenology"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jalz.2018.07.217","article-title":"Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-an emerging role for gut microbiome","volume":"15","author":"MahmoudianDehkordi","year":"2019","journal-title":"Alzheimers Dement."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"104819","DOI":"10.1016\/j.phrs.2020.104819","article-title":"Glycogen synthase kinase-3: the missing link to aberrant circuit function in disorders of cognitive dysfunction?","volume":"157","author":"Manduca","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref107","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1194\/jlr.M300369-JLR200","article-title":"Presence of protein-bound unconjugated bile acids in the cytoplasmic fraction of rat brain","volume":"45","author":"Mano","year":"2004","journal-title":"J. Lipid Res."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.molmet.2013.10.002","article-title":"Central action of FGF19 reduces hypothalamic AGRP\/NPY neuron activity and improves glucose metabolism","volume":"3","author":"Marcelin","year":"2014","journal-title":"Molec metab"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jocn.2009.05.037","article-title":"Increased acidic fibroblast growth factor concentrations in the serum and cerebrospinal fluid of patients with Alzheimer's disease","volume":"17","author":"Mashayekhi","year":"2010","journal-title":"J. Clin. Neurosci."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"e0143623","DOI":"10.1371\/journal.pone.0143623","article-title":"Secreted and transmembrane \u03b1Klotho isoforms have different Spatio-temporal profiles in the brain during aging and Alzheimer's disease progression","volume":"10","author":"Mass\u00f3","year":"2015","journal-title":"PLoS One"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1210\/me.2015-1087","article-title":"Suppression of the HPA Axis during cholestasis can be attributed to hypothalamic bile acid signaling","volume":"29","author":"McMillin","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"ref112","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tins.2013.07.001","article-title":"Sugar for the brain: the role of glucose in physiological and pathological brain function","volume":"36","author":"Mergenthaler","year":"2013","journal-title":"Trends Neurosci."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3389\/fnins.2017.00617","article-title":"Bile acid signaling pathways from the enterohepatic circulation to the central nervous system","volume":"11","author":"Mertens","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref114","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00018-013-1488-9","article-title":"Crosstalk between cerebral endothelium and oligodendrocyte","volume":"71","author":"Miyamoto","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"ref115","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0006-8993(98)01042-7","article-title":"Fibroblast growth factor (FGF)-9 immunoreactivity in senile plaques","volume":"814","author":"Nakamura","year":"1998","journal-title":"Brain Res."},{"key":"ref116","doi-asserted-by":"publisher","first-page":"26418","DOI":"10.1074\/jbc.M111.251140","article-title":"Sulfated glycosaminoglycans are required for specific and sensitive fibroblast growth factor (FGF) 19 signaling via FGF receptor 4 and betaKlotho","volume":"286","author":"Nakamura","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref117","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.neuroscience.2010.01.033","article-title":"Pigment epithelium-derived factor up-regulation induced by memantine, an N-methyl-D-aspartate receptor antagonist, is involved in increased proliferation of hippocampal progenitor cells","volume":"167","author":"Namba","year":"2010","journal-title":"Neuroscience"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jalz.2018.08.012","article-title":"Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: relationship to neuroimaging and CSF biomarkers","volume":"15","author":"Nho","year":"2019","journal-title":"Alzheimers Dement."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1742-2094-11-76","article-title":"FGF-2 released from degenerating neurons exerts microglial-induced neuroprotection via FGFR3-ERK signaling pathway","volume":"11","author":"Noda","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.bbrc.2014.11.108","article-title":"Basic fibroblast growth factor induces miR-134 upregulation in astrocyte for cell maturation","volume":"456","author":"Numakawa","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref121","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.brainres.2014.08.023","article-title":"SUN11602 has basic fibroblast growth factor-like activity and attenuates neuronal damage and cognitive deficits in a rat model of Alzheimer's disease induced by amyloid \u03b2 and excitatory amino acids","volume":"1585","author":"Ogino","year":"2014","journal-title":"Brain Res."},{"key":"ref122","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tem.2014.10.002","article-title":"Tissue-specific actions of the metabolic hormones FGF15\/19 and FGF21","volume":"26","author":"Owen","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"ref123","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/metabo7020028","article-title":"Metabolomic profiling of bile acids in clinical and experimental samples of Alzheimer's disease","volume":"7","author":"Pan","year":"2017","journal-title":"Metabolites"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/mds.25864","article-title":"The cognitive burden in Huntington's disease: pathology, phenotype, and mechanisms of compensation","volume":"29","author":"Papoutsi","year":"2014","journal-title":"Mov. Disord."},{"key":"ref125","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1007\/s12035-018-1200-z","article-title":"Klotho at the edge of Alzheimer's disease and senile depression","volume":"56","author":"Paroni","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref126","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.neurobiolaging.2019.02.011","article-title":"Systemic administration of a fibroblast growth factor receptor 1 agonist rescues the cognitive deficit in aged socially isolated rats","volume":"78","author":"Pereda-P\u00e9rez","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"6980","DOI":"10.1038\/ncomms7980","article-title":"FGF1 and FGF19 reverse diabetes by suppression of the hypothalamic-pituitary-adrenal axis","volume":"6","author":"Perry","year":"2015","journal-title":"Nat. Commun."},{"key":"ref128","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neurobiolaging.2014.10.031","article-title":"Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type","volume":"36","author":"Popp","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"9495","DOI":"10.3390\/ijms22179495","article-title":"Oligodendrocyte-specific deletion of FGFR1 reduces cerebellar inflammation and neurodegeneration in MOG35-55-induced EAE","volume":"22","author":"Rajendran","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"ref130","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00441-003-0756-7","article-title":"Fibroblast growth factors and their receptors in the central nervous system","volume":"313","author":"Reuss","year":"2003","journal-title":"Cell Tissue Res."},{"key":"ref131","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1210\/en.2012-1891","article-title":"Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats","volume":"154","author":"Ryan","year":"2013","journal-title":"Endocrinology"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1517\/13543784.2015.1006357","article-title":"Fibroblast growth factor 19-targeted therapies for the treatment of metabolic disease","volume":"24","author":"Rysz","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.yhbeh.2016.08.006","article-title":"FGF21 improves cognition by restored synaptic plasticity, dendritic spine density, brain mitochondrial function and cell apoptosis in obese-insulin resistant male rats","volume":"85","author":"Sa-Nguanmoo","year":"2016","journal-title":"Horm. Behav."},{"key":"ref134","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1016\/S0140-6736(18)31785-9","article-title":"Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial","volume":"392","author":"Sanyal","year":"2019","journal-title":"Lancet"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"e13250","DOI":"10.1111\/acel.13250","article-title":"Plasma proteomic profile of age, health span, and all-cause mortality in older adults","volume":"19","author":"Sathyan","year":"2020","journal-title":"Aging Cell"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1601-183X.2007.00357.x","article-title":"Abnormal social behaviors in mice lacking Fgf17","volume":"7","author":"Scearce-Levie","year":"2008","journal-title":"Genes Brain Behav."},{"key":"ref137","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/jnnp-2018-319148","article-title":"Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies","volume":"90","author":"Shen","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1192\/bjp.194.3.287","article-title":"Depression and dementia","volume":"194","author":"Singh","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"220","DOI":"10.2174\/1871527316666170113120853","article-title":"Synaptic plasticity, dementia and Alzheimer disease","volume":"16","author":"Skaper","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref140","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/0006-291X(90)91201-3","article-title":"Basic fibroblast growth factor in Alzheimer's disease","volume":"171","author":"Stopa","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref141","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.annonc.2022.02.001","article-title":"FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF\/FGFR alterations and advanced malignancies","volume":"33","author":"Subbiah","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref142","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature13540","article-title":"Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer","volume":"513","author":"Suh","year":"2014","journal-title":"Nature"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"101811","DOI":"10.1016\/j.redox.2020.101811","article-title":"aFGF alleviates diabetic endothelial dysfunction by decreasing oxidative stress via Wnt\/\u03b2-catenin-mediated upregulation of HXK2","volume":"39","author":"Sun","year":"2021","journal-title":"Redox Biol."},{"key":"ref144","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0006-8993(98)00552-6","article-title":"Fibroblast growth factor receptor-1 expression in the cortex and hippocampus in Alzheimer's disease","volume":"802","author":"Takami","year":"1998","journal-title":"Brain Res."},{"key":"ref145","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.2174\/1381612825666190716101411","article-title":"Therapeutic approaches to Alzheimer's type of dementia: a focus on FGF21 mediated neuroprotection","volume":"25","author":"Taliyan","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"ref146","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.bbi.2017.05.013","article-title":"Exogenous FGF2 reverses depressive-like behaviors and restores the suppressed FGF2-ERK1\/2 signaling and the impaired hippocampal neurogenesis induced by neuroinflammation","volume":"66","author":"Tang","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"ref147","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3233\/JAD-210181","article-title":"Testing for interactions between APOE and klotho genotypes on cognitive, dementia, and brain imaging metrics in UK biobank","volume":"83","author":"Tank","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"ref148","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/jnr.24996","article-title":"Normal aging, motor neurone disease, and Alzheimer's disease are characterized by cortical changes in inflammatory cytokines","volume":"100","author":"Tennakoon","year":"2022","journal-title":"J. Neurosci. Res."},{"key":"ref149","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/db18-1175","article-title":"Central and peripheral Administration of Fibroblast Growth Factor 1 improves pancreatic islet insulin secretion in diabetic mouse models","volume":"68","author":"Tennant","year":"2019","journal-title":"Diabetes"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1046\/j.1440-1789.2001.00399.x","article-title":"Locally reduced levels of acidic FGF lead to decreased expression of 28-kda calbindin and contribute to the selective vulnerability of the neurons in the entorhinal cortex in Alzheimer's disease","volume":"21","author":"Thorns","year":"2001","journal-title":"Neuropathology"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/00005072-199903000-00009","article-title":"Evidence for neuroprotective effects of acidic fibroblast growth factor in Alzheimer disease","volume":"58","author":"Thorns","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref152","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.molmet.2019.01.008","article-title":"Repeated cold exposures protect a mouse model of Alzheimer's disease against cold-induced tau phosphorylation","volume":"22","author":"Tournissac","year":"2019","journal-title":"Molec Metab"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.neuroscience.2015.07.074","article-title":"Acidic FGF promotes neurite outgrowth of cortical neurons and improves neuroprotective effect in a cerebral ischemic rat model","volume":"305","author":"Tsai","year":"2015","journal-title":"Neuroscience"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pneurobio.2017.03.008","article-title":"Synaptopathic mechanisms of neurodegeneration and dementia: insights from Huntington's disease","volume":"153","author":"Tyebji","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"ref155","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1111\/ejn.15375","article-title":"Localization of fibroblast growth factor 23 protein in the rat hypothalamus","volume":"54","author":"Ursem","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"ref156","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10637-019-00783-7","article-title":"A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma","volume":"38","author":"van Brummelen","year":"2020","journal-title":"Invest. New Drugs"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"18003","DOI":"10.1038\/nrdp.2018.3","article-title":"Vascular cognitive impairment","volume":"4","author":"van der Flier","year":"2018","journal-title":"Nat. Rev. Dis. Primers."},{"key":"ref158","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41581-018-0087-2","article-title":"Renal and extrarenal effects of fibroblast growth factor 23","volume":"15","author":"Vervloet","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"ref159","doi-asserted-by":"publisher","first-page":"147667","DOI":"10.1016\/j.brainres.2021.147667","article-title":"Prevention of vascular dementia via immunotherapeutic blockade of renin-angiotensin system in a rat model","volume":"1772","author":"Wakayama","year":"2021","journal-title":"Brain Res."},{"key":"ref160","doi-asserted-by":"publisher","first-page":"7298","DOI":"10.1007\/s12035-015-9583-6","article-title":"bFGF protects against blood-brain barrier damage through junction protein regulation via PI3K-Akt-Rac1 pathway following traumatic brain injury","volume":"53","author":"Wang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref161","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/glia.23143","article-title":"An astroglial basis of major depressive disorder? An overview","volume":"65","author":"Wang","year":"2017","journal-title":"Glia"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00253-017-8652-3","article-title":"Fibroblast growth factor 9 subfamily and the heart","volume":"102","author":"Wang","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref163","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/gps.4856","article-title":"Associations between CSF cortisol and CSF norepinephrine in cognitively normal controls and patients with amnestic MCI and AD dementia","volume":"33","author":"Wang","year":"2018","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00213-020-05699-2","article-title":"Carnosic acid alleviates depression-like behaviors on chronic mild stressed mice via PPAR-\u03b3-dependent regulation of ADPN\/FGF9 pathway","volume":"238","author":"Wang","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.1007\/s12035-017-0663-7","article-title":"FGF21 attenuates high-fat diet-induced cognitive impairment via metabolic regulation and anti-inflammation of obese mice","volume":"55","author":"Wang","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref166","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fphar.2020.00154","article-title":"FGF21 attenuated LPS-induced depressive-like behavior via inhibiting the inflammatory pathway","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref167","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.neuropharm.2017.11.027","article-title":"Impaired peripheral glucose homeostasis and Alzheimer's disease","volume":"136","author":"Wijesekara","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref168","first-page":"910","article-title":"Acid fibroblast growth factor preserves blood-brain barrier integrity by activating the PI3K-Akt-Rac1 pathway and inhibiting RhoA following traumatic brain injury","volume":"9","author":"Wu","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"ref169","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41392-020-00222-7","article-title":"FGF\/FGFR signaling in health and disease","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref170","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.bbrc.2004.06.142","article-title":"Promoter polymorphism in fibroblast growth factor 1 gene increases risk of definite Alzheimer's disease","volume":"321","author":"Yamagata","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref171","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41419-022-04765-1","article-title":"Inhibition of the CEBP\u03b2-NF\u03baB interaction by nanocarrier-packaged Carnosic acid ameliorates glia-mediated neuroinflammation and improves cognitive function in an Alzheimer's disease model","volume":"13","author":"Yi-Bin","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref172","doi-asserted-by":"publisher","first-page":"e13387","DOI":"10.1111\/acel.13387","article-title":"Role of adiponectin-notch pathway in cognitive dysfunction associated with depression and in the therapeutic effect of physical exercise","volume":"20","author":"You","year":"2021","journal-title":"Aging Cell"},{"key":"ref173","doi-asserted-by":"publisher","first-page":"109033","DOI":"10.1016\/j.biopha.2019.109033","article-title":"Effect of catalpol on behavior and neurodevelopment in an ADHD rat model","volume":"118","author":"Yuan","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref174","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.freeradbiomed.2018.10.455","article-title":"Fibroblast growth factor 9 activates anti-oxidative functions of Nrf2 through ERK signalling in striatal cell models of Huntington's disease","volume":"130","author":"Yusuf","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"ref175","doi-asserted-by":"publisher","first-page":"118952","DOI":"10.1016\/j.lfs.2020.118952","article-title":"FGF9 induces neurite outgrowth upon ERK signaling in knock-in striatal Huntington's disease cells","volume":"267","author":"Yusuf","year":"","journal-title":"Life Sci."},{"key":"ref176","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1007\/s12035-020-02220-w","article-title":"Fibroblast growth factor 9 stimulates neuronal length through NF-kB signaling in striatal cell Huntington's disease models","volume":"58","author":"Yusuf","year":"","journal-title":"Mol. Neurobiol."},{"key":"ref177","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41593-019-0372-9","article-title":"Senolytic therapy alleviates A\u03b2-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer's disease model","volume":"22","author":"Zhang","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref178","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.semcdb.2015.09.007","article-title":"Therapeutic uses of FGFs","volume":"53","author":"Zhang","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref179","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1080\/02713683.2016.1259421","article-title":"The expressions of klotho family genes in human ocular tissues and in anterior Lens capsules of age-related cataract","volume":"42","author":"Zhang","year":"2017","journal-title":"Curr. Eye Res."},{"key":"ref180","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.biopsych.2006.10.019","article-title":"Fibroblast growth factor receptor-1 is required for long-term potentiation, memory consolidation, and neurogenesis","volume":"62","author":"Zhao","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"ref181","doi-asserted-by":"publisher","first-page":"e13239","DOI":"10.1111\/acel.13239","article-title":"Klotho overexpression improves amyloid-\u03b2 clearance and cognition in the APP\/PS1 mouse model of Alzheimer's disease","volume":"19","author":"Zhao","year":"2020","journal-title":"Aging Cell"},{"key":"ref182","doi-asserted-by":"publisher","first-page":"608517","DOI":"10.3389\/fgene.2020.608517","article-title":"Association of Fibroblast Growth Factor 23 with ischemic stroke and its subtypes: a Mendelian randomization study","volume":"11","author":"Zheng","year":"2020","journal-title":"Front. Genet."},{"key":"ref183","doi-asserted-by":"publisher","first-page":"113007","DOI":"10.1016\/j.expneurol.2019.113007","article-title":"Delayed recanalization at 3 days after permanent MCAO attenuates neuronal apoptosis through FGF21\/FGFR1\/PI3K\/Caspase-3 pathway in rats","volume":"320","author":"Zheng","year":"2019","journal-title":"Exp. Neurol."},{"key":"ref184","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1681\/ASN.2013101033","article-title":"Klotho gene deficiency causes salt-sensitive hypertension via monocyte chemotactic protein-1\/CC chemokine receptor 2-mediated inflammation","volume":"26","author":"Zhou","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref185","doi-asserted-by":"publisher","first-page":"12250","DOI":"10.1038\/s41598-018-29760-5","article-title":"Differential expression of serum biomarkers in hemodialysis patients with mild cognitive decline: a prospective single-center cohort study","volume":"8","author":"Zhu","year":"2018","journal-title":"Sci. Rep."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1136266\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T04:48:44Z","timestamp":1683262124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1136266\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":185,"alternative-id":["10.3389\/fnins.2023.1136266"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2023.1136266","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,5]]},"article-number":"1136266"}}